Detalhe da pesquisa
1.
EGFR Mutation Testing: Changing Patterns of Molecular Testing in Brazil.
Oncologist
; 24(4): e137-e141, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30446583
2.
Dataset used in the economic evaluation trastuzumab-based regimens for HER-2 positive metastatic breast cancer patients in the Taiwanese healthcare setting.
Data Brief
; 29: 105194, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32071975
3.
A cost-effectiveness analysis of trastuzumab-containing treatment sequences for HER-2 positive metastatic breast cancer patients in Taiwan.
Breast
; 49: 141-148, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31805500
4.
Brigatinib for ALK-positive metastatic non-small-cell lung cancer: design, development and place in therapy.
Drug Des Devel Ther
; 13: 569-580, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30804663
5.
DNA damage repair deficiency as a predictive biomarker for FOLFIRINOX efficacy in metastatic pancreatic cancer.
J Gastrointest Oncol
; 10(6): 1133-1139, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31949930
6.
Exceptional response to FOLFIRINOX in a patient with pancreatic cancer and a germline RAD51C mutation.
J Gastrointest Oncol
; 9(4): E19-E22, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30151275
7.
What Will We Expect From Novel Therapies to Esophageal and Gastric Malignancies?
Am Soc Clin Oncol Educ Book
; 38: 249-261, 2018 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-30231398
8.
The nab-paclitaxel/gemcitabine regimen for patients with refractory advanced pancreatic adenocarcinoma.
J Gastrointest Oncol
; 9(1): 135-139, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29564179
9.
Successful use of Trastuzumab with anthracycline-based chemotherapy followed by trastuzumab maintenance in patients with advanced HER2-positive gastric cancer.
Anticancer Res
; 34(1): 301-6, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24403478